Effectiveness of low-dose mepolizumab in refractory eosinophilic granulomatosis with polyangiitis: systemic steroid use and remission
Background/Aims This study investigated the clinical efficacy of low-dose mepolizumab (100 mg) in controlling severe eosinophilic asthma, aiming to induce eosinophilic granulomatosis with polyangiitis (EGPA) remission and reduce systemic steroid usage. Additionally, we constructed a basic frame for...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
The Korean Association of Internal Medicine
2026-01-01
|
| Colección: | The Korean Journal of Internal Medicine |
| Materias: | |
| Acceso en línea: | http://kjim.org/upload/kjim-2025-130.pdf |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|